Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–2 of 2 stories
Biogen is focusing on its late-stage pipeline for multiple sclerosis as it faces increasing generic competition. The company is actively seeking partnerships to enhance its growth strategy.
Read full storyCongress has passed a landmark bill aimed at protecting patient access to specialty pharmacies, crucial for managing complex health conditions such as cancer and rare diseases. This legislation is expected to stabilize the specialty pharmacy infrastructure, enhancing innovation and patient outcomes.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.